Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for GSK2141795

1 Open Trial

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCMEL1413

03/02/2015

A Randomized Two-Arm Phase II Study of Trametinib Alone and in Combination with GSK2141795 in Patients with Advanced Uveal Melanoma